Caplin Steriles, part of Caplin Point Laboratories, obtained final approval from the US Food and Drug Administration (US FDA) ...
Researchers investigated the long-term outcomes of ab-interno canaloplasty as a standalone procedure or in combination with ...
Researchers characterized clinical outcomes following ab interno canaloplasty and trabeculotomy as a standalone procedure.
Selective laser trabeculoplasty, artificial intelligence–driven diagnostics, and new drug delivery systems are transforming ...
Caplin Point Laboratories has made headlines once again as its subsidiary, Caplin Steriles, secured the final approval from ...
The DURYSTA market potential seems strong due to the increasing prevalence of glaucoma, the need for long-term, non-adherence-dependent treatments, and its advantage over daily eye drops. With an ...
XPANCEO has emerged as a pioneer in reimagining how we interact with technology. Unlike companies developing the next ...
Glaucoma is an eye health condition that causes irreversible vision loss if not properly diagnosed and treated early. It is ...
4d
Zacks.com on MSNGKOS Crashes Almost 25% After Q4 Earnings: How to Play the Stock?Glaukos Corporation GKOS reported record fourth-quarter 2024 revenues of $105.5 million, reflecting a 28% year-over-year ...
The US contact lens market is more or less controlled by four players. Johnson & Johnson controls about a third of the market, Alcon and Cooper control roughly 25% each, and Bausch & Lomb controls 10% ...
A cardiac emergency in SPECT/CT and PET/CT occurs infrequently but necessitates prompt recognition and an appropriate response. The emergence of 18F-based myocardial perfusion radiopharmaceuticals is ...
Local medical device companies last month posted fourth quarter results that exceeded analysts’ expectations.Irvine’s Masimo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results